<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCC5E99C26D044C55BF5A352C1E93046E" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8010 IH: More Options for Infants and Parents Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-06-09</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8010</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220609">June 9, 2022</action-date><action-desc><sponsor name-id="G000558">Mr. Guthrie</sponsor> (for himself, <cosponsor name-id="G000568">Mr. Griffith</cosponsor>, <cosponsor name-id="M001180">Mr. McKinley</cosponsor>, <cosponsor name-id="A000377">Mr. Armstrong</cosponsor>, <cosponsor name-id="J000302">Mr. Joyce of Pennsylvania</cosponsor>, <cosponsor name-id="B001275">Mr. Bucshon</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn</cosponsor>, <cosponsor name-id="C001103">Mr. Carter of Georgia</cosponsor>, and <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to act upon pending submissions for new infant formula, to increase regulatory flexibility in the event of an infant formula shortage, and for other purposes.</official-title></form><legis-body id="HD3BFB8AC8B5148699AAF6EAD3986AB81" style="OLC"> 
<section id="HC253F2F4BE80443EA9F3EFE55F485A3B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>More Options for Infants and Parents Act of 2022</short-title></quote>. </text></section> <section id="H3BD0FF73465A4B6B82968409E57DA7FD"><enum>2.</enum><header>Pending submissions for new infant formula</header><text display-inline="no-display-inline">Not later than 14 days after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall act upon any pending submissions from domestic manufacturers for new infant formula under section 412(c) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a(c)</external-xref>).</text></section> 
<section id="HB762A5C76B714F7CBBE892885C560FE0"><enum>3.</enum><header>Regulatory flexibility in the event of an infant formula shortage</header><text display-inline="no-display-inline">Section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>) is amended by adding at the end the following:</text> <quoted-block style="OLC" id="HDCA5BB09143540508663393BEDC7B0B0" display-inline="no-display-inline"> <subsection id="H508FDFA1D83D43D38A318656EB4FF921"><enum>(j)</enum><header>Regulatory flexibility in the event of a shortage</header> <paragraph id="H14C04F67E0F34894A717607862B30F62"><enum>(1)</enum><header>List of products for substitution during a shortage</header><text display-inline="yes-display-inline">The Secretary shall publish and keep up-to-date a list on the internet website of the Food and Drug Administration detailing which infant formula products may be appropriate substitutes for infant formula products—</text> 
<subparagraph id="H9030DE6A565047E9A9C18141B0FA0E0B"><enum>(A)</enum><text display-inline="yes-display-inline">which the Secretary has determined to be in shortage or at risk of being in shortage; and</text></subparagraph> <subparagraph id="H8B4826417BD44C4AA3CBC3EDE5ED2DDB"><enum>(B)</enum><text>that are relied upon by infants and individuals with amino-acid and metabolic conditions.</text></subparagraph></paragraph> 
<paragraph id="H11D6B857977D449DA6D598E98DC5F0A2"><enum>(2)</enum><header>Flexibilities</header><text display-inline="yes-display-inline">The Secretary—</text> <subparagraph id="H543979548FB5486C9BC93DC8BB594CBE"><enum>(A)</enum><text>shall consider whether any infant formula products may be substituted for those in shortage; and</text></subparagraph> 
<subparagraph id="H622845A05DA341088BC4D17875DD8744"><enum>(B)</enum><text display-inline="yes-display-inline">may waive any applicable requirements under section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>) regarding labeling and nutrient content to facilitate such substitutions.</text> </subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section> </legis-body></bill>

